Author(s)

Guo Yan, Chen Jie

Corresponding Author

Guo Yan

Abstract

Hepatitis B as a serious public health disease, its effective diagnosis and treatment has been the focus of attention. Liver fibrosis and cirrhosis are important diseases of chronic hepatitis B which gradually develop into liver injury. Serious cases can cause malignant diseases such as hepatocellular carcinoma. Therefore, in this context, the early diagnosis and treatment of hepatitis B is extremely important. In order to solve the diagnostic problems of hepatic cirrhosis and liver injury caused by hepatitis B, the diagnostic accuracy of serum model of hepatic fibrosis in the diagnosis of significant cirrhosis and liver injury will be evaluated in detail based on large data samples. Then, based on the analysis of accuracy, the corresponding serological model was selected to select a suiTable model for small medical clinics to diagnose hepatitis B, and a non-invasive diagnosis model was proposed to realize the promotion of hepatitis B diagnosis in the context of large data. In the experimental part, the serum markers of hepatitis B cirrhosis and liver injury were screened and analyzed, and the diagnostic serum model of hepatitis B with popularization value was finally selected.

Keywords

Large Data Technology, Serum Model of Liver Fibrosis, Diagnostic Technology of Liver Cirrhosis and Liver Injury, Screening of Serum Markers, Large Data Sample Model